HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


‘Temperature Abuse’ Heated US Drug Recalls To Record Level In FY2022, FDA Finds

Executive Summary

Surveillance inspections nearly tripled as drug recalls reached highest level in five years, finds agency’s FY 2022 “state of pharmaceutical quality” report. Meanwhile, analysis points to lack of domestic API sources for many essential medicines.

You may also be interested in...

A Few Clouds In Sunny US FDA Review Of FY21 Drug Quality: Recalls, Investigations, Offshoring

Manufacturing sites drew high marks in FY21, especially for essential medicines and complex drugs. But inspection resumption means more recalls are coming, and inspection protocols indicate problems with investigations. Meanwhile, site data suggest post-pandemic supply chain is growing even more dispersed, particularly for essential medicines, despite government onshoring initiatives.

Family Dollar Recalls 435 Consumer Health, Personal Care Products Due To Storage Temps

Firms says products recalled were “inadvertently shipped to certain stores” after “being stored outside of labeled temperature requirements." Recalls include oral products and nasal sprays, oral care products, sunscreen and other topicals, supplements and variety of personal care SKUs.

FDA Warnings About GMP Violations Aren’t The First For Three US OTC Drug Manufacturers

Ultra Seal, Generitech, and Yusef Manufacturing indicated in responses to FDA inspectors’ findings they weren’t aware of, or capable for complying with some of the requirements imposed on them under FDA regulations for ingredient and product testing and other components of quality control.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts